Day: April 28, 2021

Constant Innovation Name of the Game in Preeclampsia Laboratory Testing Market, as per Fairfield Market Research

Staff April 28, 2021

LONDON, April 28, 2021 /PRNewswire/ -- In a recent report, Fairfield Market Research predicts that the global preeclampsia laboratory testing...

Outcomes4Me Raises $12 Million in Oversubscribed Series A to Fuel Expansion of AI-Powered Cancer Patient Empowerment Platform

Staff April 28, 2021

CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ -- Outcomes4Me Inc., developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to...

Akebia Therapeutics to Report First Quarter 2021 Financial Results and Discuss Recent Business Highlights

Staff April 28, 2021

CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the...

MedRhythms Initiates Clinical Trial and Expands Pipeline into Acute Stroke

Staff April 28, 2021

PORTLAND, Maine, April 28, 2021 /PRNewswire/ -- MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors,...

New Spherix Global Insights’ Patient Audit Highlights Key Differences Between Dermatologists’ and Rheumatologists’ Management of Psoriatic Arthritis, Focusing on Patients Recently Switched Between Advanced Systemic Treatment Brands

Staff April 28, 2021

EXTON, Pa., April 28, 2021 /PRNewswire/ -- The past five or so years have seen a flurry of US biologic...

ProductLife Group Enters US Market with Acquisition of Leading Regulatory Drug Development Consultancy DS InPharmatics (DSI)

Staff April 28, 2021

PARIS, April 28, 2021 /PRNewswire-PRWeb/ -- ProductLife Group (PLG) has taken the next step in its evolution as a global...

ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology

Staff April 28, 2021

PHILADELPHIA, April 28, 2021 /PRNewswire/ -- ERT, a global leader in clinical endpoint data solutions, today announced the close of...

Revibe Technologies Promotes Chief Technical Officer, Welcomes Chief Scientific Officer and Financial Controller as Company Develops ADHD Digital Therapeutic

Staff April 28, 2021

WAKE FOREST, N.C., April 28, 2021 /PRNewswire/ -- Revibe Technologies today announced the hiring of Dr. Lindsay Ayearst as Chief...

WELL_Health_Technologies_Corp__WELL_Health_Announces_Normal_Cour

WELL Health Announces Normal Course Issuer Bid

Staff April 28, 2021

VANCOUVER, BC, April 28, 2021 /PRNewswire/ - WELL Health Technologies Corp. (TSXV: WELL) (the "Company" or "WELL"), a company focused on...

NuvoAir Home Platform Expands to Include Cough Data

Staff April 28, 2021

BOSTON, April 28, 2021 /PRNewswire/ -- NuvoAir, a leading digital health company for chronic disease management and decentralized clinical trials, is...

Guy’s and St Thomas’ NHS Foundation Trust Selects Nuance Dragon Medical One As Part of a Large-Scale Digital Transformation

Staff April 28, 2021

BURLINGTON, Mass. and LONDON, April 28, 2021 /PRNewswire/ -- Nuance Communications, Inc. (NASDAQ: NUAN) today announced that Guy's and St...

Grifols and Andorran government will establish world-class immunology research hub to expand global knowledge of the immune system and develop therapeutics

Staff April 28, 2021

BARCELONA, Spain, April 28, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived...

Caris Life Sciences Announces Appointment of Joseph E. Gilliam to Board of Directors

Staff April 28, 2021

IRVING, Texas, April 28, 2021 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on...

Net Health Adds Industry Leader Proteus Genomics Lab Testing to Wound Care Platform

Staff April 28, 2021

PITTSBURGH, April 28, 2021 /PRNewswire/ -- Net Health, a leading provider of cloud-based software for specialty medical providers, announced today...

Caresyntax Raises $100 Million to Make Surgery Smarter and Safer

Staff April 28, 2021

BOSTON, April 28, 2021 /PRNewswire/ -- Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter...

Science and Technology of Advanced Materials Research: Article on the effects of the COVID-19 pandemic on materials

Staff April 28, 2021

TSUKUBA, Japan, April 28, 2021 /PRNewswire/ -- More than one year since the beginning of the COVID-19 outbreak, the pandemic...

Groundbreaking CBD retail portal plants new shoots across Europe

Staff April 28, 2021

LONDON, April 28, 2021 /PRNewswire/ -- Alphagreen, the UK's leading marketplace for selling CBD, is launching into six further European...

Cardamom_Market_Procurement_Research_Report

Cardamom Monitoring System: Sourcing and Procurement Report| Evolving Opportunities and New Market Possibilities| SpendEdge

Staff April 28, 2021

NEW YORK, April 28, 2021 /PRNewswire/ -- SpendEdge forecasts that the Global Cardamom Monitoring System market will grow by USD...

Kanazawa University research: Unraveling DNA packaging

Staff April 28, 2021

KANAZAWA, Japan, April 28, 2021 /PRNewswire/ -- Researchers at Kanazawa University report in the Journal of Physical Chemistry Letters how...

Mentice publishes the company’s interim report for the period January-March 2021

Staff April 28, 2021

STOCKHOLM, April 28, 2021 /PRNewswire/ -- Strongest order intake in Mentice's history despite the corona pandemic First quarter (January-March 2021)...

Day: April 28, 2021

Constant Innovation Name of the Game in Preeclampsia Laboratory Testing Market, as per Fairfield Market Research

Outcomes4Me Raises $12 Million in Oversubscribed Series A to Fuel Expansion of AI-Powered Cancer Patient Empowerment Platform

Akebia Therapeutics to Report First Quarter 2021 Financial Results and Discuss Recent Business Highlights

MedRhythms Initiates Clinical Trial and Expands Pipeline into Acute Stroke

New Spherix Global Insights’ Patient Audit Highlights Key Differences Between Dermatologists’ and Rheumatologists’ Management of Psoriatic Arthritis, Focusing on Patients Recently Switched Between Advanced Systemic Treatment Brands

ProductLife Group Enters US Market with Acquisition of Leading Regulatory Drug Development Consultancy DS InPharmatics (DSI)

ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology

Revibe Technologies Promotes Chief Technical Officer, Welcomes Chief Scientific Officer and Financial Controller as Company Develops ADHD Digital Therapeutic

WELL Health Announces Normal Course Issuer Bid

NuvoAir Home Platform Expands to Include Cough Data

Guy’s and St Thomas’ NHS Foundation Trust Selects Nuance Dragon Medical One As Part of a Large-Scale Digital Transformation

Grifols and Andorran government will establish world-class immunology research hub to expand global knowledge of the immune system and develop therapeutics

Caris Life Sciences Announces Appointment of Joseph E. Gilliam to Board of Directors

Net Health Adds Industry Leader Proteus Genomics Lab Testing to Wound Care Platform

Caresyntax Raises $100 Million to Make Surgery Smarter and Safer

Science and Technology of Advanced Materials Research: Article on the effects of the COVID-19 pandemic on materials

Groundbreaking CBD retail portal plants new shoots across Europe

Cardamom Monitoring System: Sourcing and Procurement Report| Evolving Opportunities and New Market Possibilities| SpendEdge

Kanazawa University research: Unraveling DNA packaging

Mentice publishes the company’s interim report for the period January-March 2021

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

You may have missed